Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study

References

• Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132(17):1667–1678. doi:10.1161/CIRCULATIONAHA.114.008720
   PubMed Web of Science ®Google Scholar
• Sun H, Zou X, Liu L. Epidemiological factors of stroke: a survey of the current status in china. J Stroke. 2013;15(2):109–114. doi:10.5853/jos.2013.15.2.109
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121(15):1768–1777. doi:10.1161/CIRCULATIONAHA.109.849166
   PubMed Web of Science ®Google Scholar
• Peng YP, Huang MY, Xue YJ, Pan JL, Lin C. Association of hyperhomocysteinemia with increased coronary microcirculatory resistance and poor short-term prognosis of patients with acute myocardial infarction after elective percutaneous coronary intervention. Biomed Res Int. 2020;2020:1710452. doi:10.1155/2020/1710452
   PubMed Web of Science ®Google Scholar
• Agoston-Coldea L, Mocan T, Gatfosse M, Lupu S, Dumitrascu DL. Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction. Cardiol J. 2011;18(1):55–62.
   PubMed Web of Science ®Google Scholar
• He Y, Li Y, Chen Y, Feng L, Nie Z. Homocysteine level and risk of different stroke types: a meta-analysis of prospective observational studies. Nutr Metab Cardiovasc Dis. 2014;24(11):1158–1165. doi:10.1016/j.numecd.2014.05.011
   PubMed Web of Science ®Google Scholar
• Zhang W, Sun K, Chen J, et al. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin sci. 2009;118(3):187–194. doi:10.1042/CS20090142
   PubMed Web of Science ®Google Scholar
• Han L, Wu Q, Wang C, et al. Homocysteine, ischemic stroke, and coronary heart disease in hypertensive patients: a population-based, prospective cohort study. Stroke. 2015;46(7):1777–1786. doi:10.1161/STROKEAHA.115.009111
   PubMed Web of Science ®Google Scholar
• Wang CY, Chen ZW, Zhang T, et al. Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients. Eur J Intern Med. 2014;25(6):538–544. doi:10.1016/j.ejim.2014.04.011
   PubMed Web of Science ®Google Scholar
• Marti-Carvajal AJ, Sola I, Lathyris D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2015;1:Cd006612.
   PubMed Web of Science ®Google Scholar
• Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313(13):1325–1335. doi:10.1001/jama.2015.2274
   PubMed Web of Science ®Google Scholar
• Shi Z, Guan Y, Huo YR, et al. Elevated total homocysteine levels in acute ischemic stroke are associated with long-term mortality. Stroke. 2015;46(9):2419–2425. doi:10.1161/STROKEAHA.115.009136
   PubMed Web of Science ®Google Scholar
• Sun Y, Chien KL, Hsu HC, Su TC, Chen MF, Lee YT. Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study. Circ j. 2009;73(8):1423–1430. doi:10.1253/circj.CJ-08-1077
   PubMed Web of Science ®Google Scholar
• Towfighi A, Arshi B, Markovic D, Ovbiagele B. Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: the impact of age in the VISP trial. Cerebrovascular Dis. 2014;37(4):263–267. doi:10.1159/000360153
   PubMed Web of Science ®Google Scholar
• Tang Z, Zhou T, Luo Y, et al. Risk factors for cerebrovascular disease mortality among the elderly in Beijing: a competing risk analysis. PLoS One. 2014;9(2):e87884. doi:10.1371/journal.pone.0087884
   PubMed Web of Science ®Google Scholar
• Zhang Z, Fang X, Hua Y, et al. Combined effect of hyperhomocysteinemia and hypertension on the presence of early carotid artery atherosclerosis. J Stroke Cerebrovascular Dis. 2016;25(5):1254–1262. doi:10.1016/j.jstrokecerebrovasdis.2016.01.037
   PubMed Web of Science ®Google Scholar
• Zimmer Z, Fang X, Tang Z. Fifteen-year disability trends among older persons in the Beijing municipality of China. J Aging Health. 2014;26(2):207–230. doi:10.1177/0898264313513609
   PubMed Web of Science ®Google Scholar
• Endris T, Worede A, Asmelash D. Prevalence of diabetes mellitus, prediabetes and its associated factors in dessie town, northeast ethiopia: a community-based study. Diabetes Metab Syndrome Obesity. 2019;12:2799–2809. doi:10.2147/DMSO.S225854
   PubMed Web of Science ®Google Scholar
• Lai MMY, Sharman MJ, Ames DJ, et al. Relationship of established cardiovascular risk factors and peripheral biomarkers on cognitive function in adults at risk of cognitive deterioration. J Alzheimers Dis. 2020;74(1):163–171. doi:10.3233/JAD-190953
   PubMed Web of Science ®Google Scholar
• Yu S, Chen Y, Yang H, Guo X, Zheng L, Sun Y. Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese. BMC Cardiovasc Disord. 2020;20(1):44. doi:10.1186/s12872-020-01350-2
   PubMed Web of Science ®Google Scholar
• Ameriacan Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care. 2011;34(Suppl 1):S11–S61. doi:10.2337/dc11-S011
   PubMedGoogle Scholar
• Joint Committee. [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(5):390–419. Chinese.
   PubMedGoogle Scholar
• Tiongco RE, Bituin A, Arceo E, Rivera N, Singian E. Salivary glucose as a non-invasive biomarker of type 2 diabetes mellitus. J clin exp dent. 2018;10(9):e902–e907. doi:10.4317/jced.55009
   PubMedGoogle Scholar
• Polak JF, Pencina MJ, Pencina KM, O’Donnell CJ, Wolf PA, D’Agostino RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011;365(3):213–221. doi:10.1056/NEJMoa1012592
   PubMed Web of Science ®Google Scholar
• Yao ES, Tang Y, Xie MJ, Wang MH, Wang H, Luo X. Elevated homocysteine level related to poor outcome after thrombolysis in acute ischemic stroke. Med Sci Monit. 2016;22:3268–3273. doi:10.12659/MSM.900010
   PubMed Web of Science ®Google Scholar
• Luo JL, Chien KL, Hsu HC, et al. Association between plasma homocysteine concentration and the risk of all-cause death in adults with diastolic dysfunction in a community: a 13-year cohort study. Medicine. 2017;96(17):e6716. doi:10.1097/MD.0000000000006716
   PubMed Web of Science ®Google Scholar
• Wong YY, Almeida OP, McCaul KA, Yeap BB, Hankey GJ, Flicker L. Homocysteine, frailty, and all-cause mortality in older men: the health in men study. j Gerontology Ser a Biol Sci Med Sci. 2013;68(5):590–598. doi:10.1093/gerona/gls211
   PubMed Web of Science ®Google Scholar
• Mendonca N, Jagger C, Granic A, et al. Elevated total homocysteine in all participants and plasma vitamin b12 concentrations in women are associated with all-cause and cardiovascular mortality in the very old: the newcastle 85+ study. J Gerontol a Biol Sci Med Sci. 2018;73(9):1258–1264. doi:10.1093/gerona/gly035
   PubMed Web of Science ®Google Scholar
• Naruszewicz M, Jankowska EA, Zymlinski R, et al. Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance–pilot study. Atherosclerosis. 2007;194(2):408–414. doi:10.1016/j.atherosclerosis.2006.08.014
   PubMed Web of Science ®Google Scholar
• Okura T, Miyoshi K, Irita J, et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci Rep. 2014;4(1):5663. doi:10.1038/srep05663
   PubMed Web of Science ®Google Scholar
• Swart KM, van Schoor NM, Blom HJ, Smulders YM, Lips P. Homocysteine and the risk of nursing home admission and mortality in older persons. Eur J Clin Nutr. 2012;66(2):188–195. doi:10.1038/ejcn.2011.186
   PubMed Web of Science ®Google Scholar
• Loscalzo J, Handy DE. Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulm Circ. 2014;4(2):169–174. doi:10.1086/675979
   PubMed Web of Science ®Google Scholar
• Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14(1):6. doi:10.1186/1475-2891-14-6
   PubMed Web of Science ®Google Scholar